Genome-wide Association Study Identifies Variations in 6p21.3 Associated With Nevirapine-Induced Rash

Abstract

We demonstrated that genetic variations in CCHCR1 are strongly associated with nevirapine-induced rash. A predictive model that includes genetic and clinical risk factors for nevirapine-associated rash might be useful in lowering the incidence of rash associated with nevirapine initiation among HIV-infected patients.